Related Experiment Video
Updated: Feb 10, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Development of a Risk Score Based on Aortic Calcification to Predict 1-Year Mortality After Transcatheter Aortic
Pierre Lantelme1, Hélène Eltchaninoff2, Muriel Rabilloud3
1Cardiology Department, Hôpital Croix-Rousse and Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France; University of Lyon, CREATIS UMR5220, INSERM U1044, INSA-15 Lyon, France.
Insights
A new risk score using thoracic aortic calcification (TAC) effectively predicts cardiovascular and all-cause mortality after transcatheter aortic valve replacement (TAVR). This CAPRI score aids in identifying patients at higher risk, improving clinical decision-making.
Area of Science:
- Cardiology
- Radiology
- Medical Informatics
Background:
- Aortic calcification is linked to poorer outcomes following transcatheter aortic valve replacement (TAVR).
- A risk score incorporating aortic calcification could identify patients with unfavorable prognoses after TAVR.
Purpose of the Study:
- To develop and validate a novel scoring system, the CAPRI score, utilizing thoracic aortic calcification (TAC) to predict 1-year mortality.
- To assess the predictive value of TAC in conjunction with other clinical factors for cardiovascular and all-cause mortality.
Main Methods:
- The C4CAPRI study involved a training cohort (1,425 TAVR patients, 2010-2014) and a test cohort (311 TAVR patients, 2015).
- Thoracic aortic calcification (TAC) was quantified via computed tomography before TAVR.
- CAPRI risk scores were derived from Cox models incorporating TAC, comorbidities, demographics, atherosclerotic disease, and cardiac function, then validated in independent cohorts.
Main Results:
- One-year cardiovascular and all-cause mortality rates were 13.0% and 17.9% in the training cohort, and 8.2% and 11.8% in the test cohort.
- Each 1-cm³ increase in TAC correlated with a 6% rise in cardiovascular mortality and a 4% rise in all-cause mortality.
- The CAPRI model demonstrated fair predictive power (AUC 68%) for both outcomes, with high correlation between predicted and observed survival, consistent across cohorts.
Conclusions:
- The CAPRI score, integrating TAC with established prognostic factors, accurately predicts 1-year cardiovascular and all-cause mortality.
- Validation in an independent cohort confirms the score's predictive performance and clinical relevance for decision-making in TAVR.
- Routine use of the CAPRI score may help optimize patient selection and potentially prevent futile interventions.
Objectives:
The aim of this study was to develop a new scoring system based on thoracic aortic calcification (TAC) to predict 1-year cardiovascular and all-cause mortality.
Background:
A calcified aorta is often associated with poor prognosis after transcatheter aortic valve replacement (TAVR). A risk score encompassing aortic calcification may be valuable in identifying poor TAVR responders.
Methods:
The C4CAPRI (4 Cities for Assessing CAlcification PRognostic Impact) multicenter study included a training cohort (1,425 patients treated using TAVR between 2010 and 2014) and a contemporary test cohort (311 patients treated in 2015). TAC was measured by computed tomography pre-TAVR. CAPRI risk scores were based on the linear predictors of Cox models including TAC in addition to comorbidities and demographic, atherosclerotic disease and cardiac function factors. CAPRI scores were constructed and tested in 2 independent cohorts.
Results:
Cardiovascular and all-cause mortality at 1 year was 13.0% and 17.9%, respectively, in the training cohort and 8.2% and 11.8% in the test cohort. The inclusion of TAC in the model improved prediction: 1-cm3 increase in TAC was associated with a 6% increase in cardiovascular mortality and a 4% increase in all-cause mortality. The predicted and observed survival probabilities were highly correlated (slopes >0.9 for both cardiovascular and all-cause mortality). The model's predictive power was fair (AUC 68% [95% confidence interval [CI]: 64% to 72%]) for both cardiovascular and all-cause mortality. The model performed similarly in the training and test cohorts.
Conclusions:
The CAPRI score, which combines the TAC variable with classical prognostic factors, is predictive of 1-year cardiovascular and all-cause mortality. Its predictive performance was confirmed in an independent contemporary cohort. CAPRI scores are highly relevant to current practice and strengthen the evidence base for decision making in valvular interventions. Its routine use may help prevent futile procedures.
Related Concept Videos
Aortic Regurgitation I: Introduction
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Aortic Regurgitation III: Medical Management
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Piaget's Stage 1 of Cognitive Development
Exploration...

